Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 2/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Infection, Lyme disease, Wheelchair user, Refusal of treatment by patient
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1601USA006167
Write-up:This spontaneous social media report was received from a patient''s parent via web page and refers to a female patient of unknown age. The patient''s medical history and current conditions were not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL (lot #, expiration date, dose and route of administration were not reported). Secondary suspects and concomitant therapies were not reported. On an unknown date, the patient was diagnosed with co-infector and Lyme illiterate state. The patient was refused a standard anti-biotic treatment. There was some "permed ant damage" from going years without treatment. The patient underwent alternative, non-invasive treatment. The outcome of adverse events was reported as drastic improvement as the patient went from asking for a wheelchair to applying to college within days. The relatedness between adverse events and GARDASIL was not reported. Upon internal review, the events were considered to be disabling as the reporter stated that they caused permanent damage. This is one of several reports received from the same source. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166